Change Company Name
 
Divis Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code
532488
NSE Symbol
DIVISLAB
P/E
67.87
ISIN Demat
INE361B01024
Div & Yield %
0.47
EPS
94.7
Book Value
578.26
Market Cap (Rs Cr.)
170,614.00
Face Value
2
Stock Price Details
Last Price (₹) 6,371.10
Change -5.25 (-0.08%)
Best Buy (₹) 0
Best Sell (₹) 0
Today's Range 6,371.10 - 6,500.00
52-Week Range 4,941.70 - 7,077.70
Beta (1 Year) 0.77
Chart
1 Day | 5 Day | 3 Month | 1 Year | 5 Year
Index Details
BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50, bse carbonex
Corporate Announcements
Divis Laboratories Ltd eases for fifth straight session
Divi's Laboratories standalone net profit rises 34.36% in the September 2025 quarter
Divi's Laboratories consolidated net profit rises 35.10% in the September 2025 quarter
Divis Laboratories Ltd - Divis Laboratories Limited - Appointment
Divis Laboratories Ltd - Divis Laboratories Limited - Outcome of Board Meeting
Divis Laboratories to announce Quarterly Result
Divis Laboratories Ltd - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Divis Laboratories Ltd - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Divis Laboratories Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
Divis Laboratories Ltd - Divis Laboratories Limited - Copy of Newspaper Publication
Corporate Details
Incorporation Year : 1990
Chairman : Ramesh B V Nimmagadda
Ownership Group : Indian Private
Sector : Pharmaceuticals
Industry : Pharmaceuticals - Indian - Bulk Drugs
Registered Office :

Divis Laboratories Ltd
1-72-23(P)/DIVIS/303 Divi Towe,
Cyber Hills Gachibowli,
Hyderabad,
Telangana - 500032,
Phone : 91-40-23786300/23786352/400,
Fax : 91-40-23786460
E-Mail : mail@divislaboratories.com; cs@divislaboratories.c
URL : http://www.divislabs.com
Investor Returns
Period Date Price() Returns (%)
1Week 05-Dec-2025 6,473.35 -0.72
1Month 12-Nov-2025 6,519.30 -1.42
3Month 12-Sep-2025 6,026.55 6.64
6Month 12-Jun-2025 6,722.75 -4.40
1Year 12-Dec-2024 5,946.95 8.07
Mutual Funds Holding
Scheme Name % Holding Market Value (₹.Cr)
SBI Equity Hybrid Fund 2.89 2396.49
SBI Large Cap Fund 3.18 1769.33
SBI Focused Fund 2.68 1146.43
AXIS ELSS Tax Saver Fund 2.11 740.86
AXIS Focused Fund 5.12 637.31
Peer Groups : Pharmaceuticals - Indian - Bulk Drugs
Company Last Price() Change(%) 52Week High() 52Week Low() Market Cap()
Neuland Laboratories Ltd 16,076.60 -0.95 19,748.40 10,060.00 20,626.10
Jubilant Pharmova Ltd 1,084.90 -0.74 1,250.00 823.70 17,282.46
Acutaas Chemicals Ltd 1,664.75 -0.10 1,901.35 919.63 13,629.50
Dishman Pharmaceuticals and Chemicals Ltd(Merged) 301.05 0.00 0.00 0.00 4,858.77
Gujarat Themis Biosyn Ltd 392.00 0.58 479.45 192.35 4,271.44